image
Healthcare - Medical - Devices - NYSE - US
$ 75.245
-0.253 %
$ 44.1 B
Market Cap
31.48
P/E
CASH FLOW STATEMENT
542 M OPERATING CASH FLOW
-39.46%
2.31 B INVESTING CASH FLOW
1230.78%
-983 M FINANCING CASH FLOW
-38.26%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Edwards Lifesciences Corporation
image
2b2b1b1b1b1b1b1b800m800m600m600m400m400m200m200m0020162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income 4.17 B
Depreciation & Amortization 155 M
Capital Expenditures -252 M
Stock-Based Compensation 162 M
Change in Working Capital -259 M
Others -3.58 B
Free Cash Flow 290 M

Cash Flow

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999
OPERATING CASH FLOW
Net Income 4 169.7 1 402.4 1 521.9 1 503.1 823.4 1 046.9 722.2 583.6 569.5 494.9 811.1 391.7 293.2 236.7 218.0 229.1 128.9 113.0 130.5 79.3 1.7 79.0 55.7 (11.0) (272.0) 82.0
Depreciation & Amortization 155.2 144.9 139.6 134.8 107.2 89.3 77.4 81.9 71.2 65.8 68.6 68.7 57.3 58.0 56.5 58.7 55.6 54.8 56.8 56.2 55.7 45.6 40.4 57.0 74.0 84.0
Deferred Income Tax (323.4) (272.1) (254.5) (41.4) (49.4) 12.1 (27.3) 17.8 (37.4) (95.0) (71.1) 100 K 8.1 (0.6) (11.2) (4.0) (23.5) (5.6) 7.1 (13.8) 0.8 5.3 (13.8) (30.0) 0 0
Stock Based Compensation 162.3 139.4 126.8 109.3 92.6 81.3 71.0 61.6 56.9 49.9 48.3 47.4 42.1 35.0 29.3 28.3 28.7 27.7 26.6 0 0 0 0 0 0 0
Other Operating Activities (3 362.2) 7.5 105.8 (119.0) 38.3 154.1 126.1 21.6 (21.9) (30.3) (24.9) (56.7) (38.4) 15.1 (40.1) (78.5) 33.0 16.2 24.7 18.7 119.6 12.3 74.6 8.0 347.0 11.0
Change in Working Capital (259.3) (526.3) (421.4) 145.3 42.2 (204.3) (42.6) 234.2 66.1 64.4 190.3 21.5 11.5 (29.7) (1.1) (68.3) (69.5) 4.1 (14.9) (3.6) 2.8 (19.9) (36.3) (5.0) (12.0) (1.0)
Cash From Operations 542.3 895.8 1 218.2 1 732.1 1 054.3 1 179.4 926.8 1 000.7 704.4 549.7 1 022.3 472.7 373.8 314.5 251.4 165.3 153.2 210.2 230.8 136.8 180.6 122.3 120.6 101.0 137.0 176.0
INVESTING CASH FLOW
Capital Expenditures (252.4) (266.3) (264.8) (329.8) (407.3) (278.4) (241.7) (175.5) (217.4) (106.5) (93.7) (110.1) (127.7) (90.6) (63.0) (64.0) (78.0) (62.5) (59.4) (48.5) (42.5) (37.9) (40.7) (38.0) (46.0) (42.0)
Other Items 2 565.3 440.1 517.1 (1 392.7) (123.8) (317.4) 318.4 (471.7) 5.7 (209.6) (539.3) (302.6) 37.2 (322.2) 1.5 104.1 136.8 (82.0) 23.7 21.3 (134.6) (25.4) (27.6) 34.0 (29.0) (7.0)
Cash From Investing Activities 2 312.9 173.8 252.3 (1 722.5) (531.1) (595.8) 76.7 (647.2) (211.7) (316.1) (633.0) (412.7) (90.5) (412.8) (61.5) 40.1 58.8 (144.5) (35.7) (27.2) (177.1) (63.3) (68.3) (4.0) (75.0) (49.0)
FINANCING CASH FLOW
Common Stock Repurchased (1 159.4) (879.6) (1 727.1) (512.8) (625.4) (263.3) (795.5) (763.3) (662.3) (280.1) (300.9) (496.9) (344.1) (303.4) (200.0) (95.5) (306.5) (130.9) (145.9) (53.5) (59.1) (49.4) (30.8) 0 0 0
Total Debt Repaid 0 (0.3) (0.2) (1.8) (0.8) (10.0) (437.3) 176.3 222.1 1.9 (12.7) 409.6 39.5 104.4 (48.4) (84.6) 94.2 (27.9) (85.9) 59.1 7.1 (4.0) (82.1) (91.0) 441.0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 176.4 168.9 142.8 158.3 139.3 157.7 131.6 113.8 171.7 119.6 160.6 122.2 149.0 63.8 144.5 21.6 14.4 12.0 4.7 (2.8) 1.0 (4.4) 29.7 13.0 (482.0) (127.0)
Cash From Financing Activities (983.0) (711.0) (1 584.5) (356.3) (486.9) (115.6) (1 101.2) (473.2) (268.5) (158.6) (153.0) 34.9 (155.6) (135.2) (103.9) (91.8) (134.1) (108.1) (193.6) 29.0 (20.5) (15.0) (69.5) (78.0) (37.0) (127.0)
CHANGE IN CASH
Net Change In Cash 1 910.8 375.4 (94.8) (332.8) 15.8 465.0 (104.2) (111.8) 211.7 64.6 233.4 109.5 139.7 (224.9) 62.0 115.4 76.9 (41.0) 4.2 129.7 (12.2) 26.9 (13.5) 20.0 28.0 0
FREE CASH FLOW
Free Cash Flow 289.9 629.5 953.4 1 402.3 647.0 901.0 685.1 825.2 487.0 443.2 928.6 362.6 246.1 223.9 188.4 101.3 75.2 147.7 171.4 88.3 138.1 84.4 79.9 63.0 91.0 134.0